Cibc World Markets Corp and
Prudential PLC have newly acquired shares in
STERIS plc (STE), while
Northern Trust Corp and
Envestnet Asset Management Inc. have sold significant shares.
STERIS stock has generally underperformed compared to competitors, despite daily gains and strong trading days.
Stephens Inc. AR and
Tower Research Capital LLC TRC boosted their positions, while
Allianz Asset Management GmbH cut its stake. The company's consensus rating from analysts is 'Moderate Buy’ with a target price set at $241.60. Significant insider sales occurred, namely SVP and President, Healthcare Cary Majors. STERIS was upgraded and then downgraded by StockNews.com. The company posted strong Q3 and Q4 Fiscal 2024 earnings results, with positive investor returns over the past five years. However, market sentiment remains mixed due to its mixed fundamentals. It achieved a new 52-week high and has favorable earning estimates projected for Q1 2025. It sold its dental segment to
HuFriedy Group. Eventually, it surpassed revenue forecasts and adjusted EPS expectations for Fiscal 2024. Despite some market underperformance, investors are encouraged to buy STERIS due to its long-term growth potential.
Steris Plc STE News Analytics from Mon, 15 Jun 2020 07:00:00 GMT to Sun, 09 Jun 2024 15:52:59 GMT -
Rating 0
- Innovation 7
- Information 8
- Rumor 5
